Neovasc Inc.

Recent News

  • Neovasc Reducer(TM) and Tiara(TM) Featured at Leading Industry Virtual Conferences

    Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - June 29, 2020) - Neovasc, Inc. (NASDAQ: NVCN), (TSX: NVCN) ("Neovasc" or the "Company"), today announced that the Neovasc Reducer™ ("Reducer") and Tiara™ ("Tiara") program were recently featured at two industry conferences.The Tiara Mitral Valve Replacement program was featured at both the...

    2020-06-29 12:00 PM ET
  • Neovasc Announces Positive Interim Results from REDUCER-I Study

    Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - June 26, 2020) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced positive interim results of the REDUCER-I study during the PCR E-Course. Stefan Verheye, MD, PhD, ZNA Middelheim, Antwerp, Belgium presented the results of the trial during...

    2020-06-26 9:45 AM ET
  • Neovasc Regains Compliance with Nasdaq Minimum Market Value Rule

    Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - June 25, 2020) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") announced that it received written notification yesterday (the "Nasdaq Notice") from the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it has regained compliance with the...

    2020-06-25 9:00 AM ET
  • Neovasc Announces Closing of $11.5 Million Registered Direct Offering Priced At-The-Market

    Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - June 16, 2020) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, and minimally invasive devices for the treatment of refractory angina, announced today that it has closed...

    2020-06-16 2:22 PM ET
  • Neovasc Announces $11.5 Million Registered Direct Offering Priced At-The-Market

    Vancouver, British Columbia--(Newsfile Corp. - June 12, 2020) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") announced today that it has entered into definitive agreements with certain healthcare-focused institutional investors for the sale of an aggregate of 3,883,036 common shares at a purchase price of US$2.97375 per...

    2020-06-12 9:00 AM ET
  • Neovasc Reducer(TM) and Tiara(TM) Program to be Highlighted at Leading Industry Virtual Conferences

    Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - June 9, 2020) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") , a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, and minimally invasive devices for the treatment of refractory angina, announced today that the Neovasc...

    2020-06-09 9:00 AM ET
  • Neovasc Announces Closing of Final Convertible Debt Issuance for Gross Proceeds of US$5.0 Million

    Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - June 4, 2020) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, and minimally invasive devices for the treatment of refractory angina, announced today that, further to its press...

    2020-06-04 9:00 AM ET
  • Neovasc Reducer Spotlighted in Leading German Public Television Program

    Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - June 3, 2020) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, and minimally invasive devices for the treatment of refractory angina, today announced that the Neovasc Reducer™ device...

    2020-06-03 9:57 AM ET